Latest Conference Articles

Safiya Tisdell, vice president of Adparo Services at Annexus Health, details the available assistance options designed to ease the financial burden associated with accessing care for both patients and providers.

Two posters presented at ASHP Midyear 2023 explored the impact of diabetes management interventions among patients with diabetes.

The analysis revealed deeper issues created by payer and manufacturer lockouts placed on Integrated Health System Specialty Pharmacies.

Two posters presented at ASHP 2023 Midyear examined how accurate answers were from the artificial intelligence chatbot.

Investigators developed a new Plan-Do-Study-Act cycle to meet standards of USP <800> at a central-fill pharmacy.

A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.

Increased clinical awareness around the value of lithium monitoring was ultimately achieved.

A study presented at ASHP Midyear 2023 found that primary care physicians said a refill management service helped reduce burnout and improved the quality of patient care.

A Q&A with Lisa McCabe, PharmD, MBA, BSN, director of Health System Pharmacy at Cardinal Health.

Study results outlined in a poster at ASHP Midyear 2023 revealed that virtual delivery education programs could contribute to a more inclusive and accessible health care information landscape for Black older adults.

These populations are also more likely to receive opioid analgesic therapies.

The CDC first released opioid prescribing guidelines in 2016.

Updated guidance from the United States Preventive Services Task Force advises against low-dose aspirin use as a primary prevention of atherosclerotic cardiovascular disease in certain populations who have bleeding risks.

A poster presented at ASHP Midyear 2023 highlighted the positive impact of including pharmacists in the care of postpartum women at risk of persistently elevated blood pressure (BP), particularly in cases of portopulmonary hypertension (PPHTN).

According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.

A poster from ASHP Midyear 2023 demonstrated the effectiveness of liposomal bupivacaine as it is used for cesarean section procedures, regarded as an area with increasing utilization.

According to a poster presented at ASHP Midyear 2023, stress ulcer prophylaxis (SUP) did not increase adverse effects, suggesting limited preventive benefits for gastrointestinal bleeding (GIB) in neonates.

Three poster presented at the ASHP Midyear Clinical Meeting delved deeper into perioperative pain management.

An evaluative study on an open resource Instagram page that provides information on new medications to pharmacists was recently presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition.

In a conversation from this year's Healthcare Advocate Summit, Randy Falkenrath demystified the oncology medication management model and explained how specialty pharmacist can help patients access care.

Presenters at a NCPA 2023 session highlighted the importance of overcoming hesitations to implement new clinical services and taking an employee-centric approach in doing so.

Tiffany Capps, CPhT, pharmacy operations manager at Galloway-Sands Pharmacy in North Carolina and marketing communications manager at CPESN, discusses how pharmacies can utilize med sync programs and what they can expect when implementing one.

Mary Stoner, president of Electronic Billing Services Inc., sat down with Drug Topics at NCPA 2023 to discuss the billing process for non-dispensing services in pharmacies.

Anesthetic gases and meter dose inhalers, how we use our antibiotics, how we use our resources for infection prevention and control, and how we use plastic and food in our hospitals all add up.

Pediatric TB is an intricate challenge that demands continued attention and funding.

Prophylactic HPV vaccines have demonstrated remarkable efficacy, exceeding 98%, and they are already proving to be effective in the prevention of anogenital warts, precancerous lesions, and cancer alike.

Isaac "Zak" Kohane, MD, PhD, the inaugural chair of Harvard Medical School's Department of Biomedical Informatics, discussed artificial intelligence during a plenary session at IDWeek 2023.